HC Wainwright & Co. Reiterates Buy on Compugen, Maintains $4 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 85.4%

Neg 0% Neu 85.4% Pos 0%

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Compugen (NASDAQ:CGEN) with a Buy and maintains $4 price target.